ArticleTherapeutic innovation & regulatory science2026

Enhancing Data Quality in Clinical Trials: Cross-Company Validation of the Open-Source Clinical Trial Anomaly Spotter (CTAS).

Pekka Tiikkainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.